1 / 27

Table of Content - Global NIPT Market Report

The global non-invasive prenatal market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031.

bisreports
Download Presentation

Table of Content - Global NIPT Market Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. De Global Non- Invasive Prenatal Testing (NIPT) Market Table of Content GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET https://www.freepik.com/search?dates=anyandformat=searchandpage=1andquery=empty-cockpit-vehicle-hud-head-up-display-digital-speedometer- autonomous-andsort=popular Focus on Method, Test, Platform, End User, Application and Country Analysis Analysis and Forecast: 2020-2031 December 2021 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Copyright © 2021 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content 1.Product Definition ...................................................................... 37 1.1 Inclusion and Exclusion .................................................................................. 37 2.Scope of the Work ...................................................................... 38 2.1 Overview: Report Scope ................................................................................. 38 2.2 Segmentation of the Global NIPT Market ....................................................... 39 2.3 Assumptions and Limitations ......................................................................... 39 2.4 Key Questions Answered in the Report......................................................... 40 2.5 Base Year and Forecast Period ...................................................................... 42 3.Research Methodology .............................................................. 43 3.1 Overview: Report Methodology ...................................................................... 43 3.2 Primary Data Sources ..................................................................................... 44 3.3 Secondary Data Sources ................................................................................ 44 3.4 Market Estimation Model ................................................................................. 46 3.5 Criteria for Company Profiling ........................................................................ 48 4.Market Overview ........................................................................ 49 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 4.1 Introduction ...................................................................................................... 49 4.2 Factors Influencing the Adoption of NIPT ..................................................... 49 4.3 NIPT Approach ................................................................................................. 50 4.4 Different Methods of NIPT ............................................................................... 51 4.5 Benefits and Risks Associated with NIPT ..................................................... 52 4.6 Chromosomal Aneuploidy .............................................................................. 52 4.7 Features and Incidence Rate of Major Chromosomal Aneuploidies ........... 55 4.8 Technological Advancements ........................................................................ 57 4.9 World Economic Outlook of Non-Invasive Prenatal Testing Market, 2019 ................................................................................................................... 59 4.10Global Footprint ............................................................................................... 60 3 All rights reserved at BIS Research Inc.

  4. 5.Market Dynamics ....................................................................... 62 5.1 Overview ........................................................................................................... 62 5.2 Impact Analysis ............................................................................................... 62 5.3 Market Drivers .................................................................................................. 64 5.3.1Increased Emphasis on Early Detection and Prevention ......................... 64 5.3.2Availability of Advanced Screening Technologies ................................... 65 5.3.3Increasing Consumer Demand ................................................................... 65 5.3.4Shifting of Reimbursement Policies Toward More Genetics Coverage ...................................................................................................... 66 5.3.5High Incidence Rate of Down’s Syndrome ................................................ 67 5.3.6Rising Average Maternal Age ..................................................................... 68 5.3.7Increasing Prevalence of Genetic and Congenital Disorders .................. 68 5.4 Market Restraints ............................................................................................. 69 5.4.1Stringent Regulatory Guidelines and Ethical Hurdles ............................. 69 5.4.2Limitations of NIPT ...................................................................................... 70 5.4.3Lack of Awareness Among Consumers .................................................... 70 5.4.4Alternative Screening and Testing Methods ............................................. 70 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 5.5 Market Opportunities ....................................................................................... 71 5.5.1Capitalizing on the Potential Presented by the Emerging Markets in Asia ........................................................................................................... 71 5.5.2Availability of Direct-to-Consumer Tests .................................................. 71 5.5.3Focus on Pre-Implantation Genetic Diagnosis ......................................... 72 6.Industry Insights ........................................................................ 73 6.1 Regulatory Framework .................................................................................... 73 6.1.1Regulatory Scenario in the U.S. ................................................................. 73 6.1.2Regulatory Scenario in Canada.................................................................. 74 6.1.3Regulatory Scenario in the U.K. ................................................................. 74 6.1.4Regulatory Scenario in Germany ............................................................... 75 4 All rights reserved at BIS Research Inc.

  5. 6.1.5Regulatory Scenario in France ................................................................... 75 6.1.6Regulatory Scenario in Spain ..................................................................... 75 6.1.7Regulatory Scenario in Italy ....................................................................... 76 6.1.8Regulatory Scenario in the Netherlands ................................................... 76 6.1.9Regulatory Scenario in China .................................................................... 76 6.1.10Regulatory Scenario in India ...................................................................... 76 6.1.11Regulatory Scenario in Australia ............................................................... 76 6.1.12Regulatory Scenario in Japan .................................................................... 77 6.2 Clinical Laboratory Improvement Amendments (CLIA) Program ................ 77 6.2.1Regulatory Authorities Involved in CLIA Program ................................... 78 6.3 Cost and Access .............................................................................................. 79 6.4 Reimbursement Scenario ................................................................................ 79 6.5 Funding Scenario ............................................................................................ 81 6.6 Supply Chain .................................................................................................... 83 6.7 Impact of COVID-19 Outbreak on the Global NIPT Market ........................... 84 7.Competitive Landscape ............................................................. 86 7.1 Overview ........................................................................................................... 86 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 7.2 Key Developments and Strategies ................................................................. 87 7.2.1New Offerings .............................................................................................. 88 7.2.2Partnerships and Alliances ........................................................................ 89 7.2.3Product Approvals ...................................................................................... 90 7.2.4Business Expansions ................................................................................. 91 7.2.5Merger and Acquisition Activities .............................................................. 91 7.2.6Others ........................................................................................................... 92 7.3 Market Share Analysis .................................................................................... 93 7.4 Growth Share Analysis (Opportunity Mapping) ............................................ 94 7.4.1by Platform ................................................................................................... 94 8.Global NIPT Market (by Test), 2020-2031 ................................... 96 5 All rights reserved at BIS Research Inc.

  6. 8.1 Overview ........................................................................................................... 96 8.2 Panorama and Vistara ..................................................................................... 97 8.3 MaterniT GENOME, MaterniT 21 PLUS, and informaSeq.............................. 99 8.4 Verifi and Verifi Plus Prenatal Tests ............................................................ 100 8.5 Harmony Test ................................................................................................. 102 8.6 NIFTY Test and NIFTY-Test Pro .................................................................... 103 8.7 QNatal Advanced ........................................................................................... 104 8.8 PrenaTest, GeneSafe, and PrenatalSAFE .................................................... 105 8.9 Bambni Test ................................................................................................... 106 8.10IONA and Sage ............................................................................................... 107 8.11Others ............................................................................................................. 108 9.Global NIPT Market (by Method), 2020-2031 ............................. 110 9.1 Overview ......................................................................................................... 110 9.2 cfDNA .............................................................................................................. 112 9.3 FCMB .............................................................................................................. 114 10.Global NIPT Market (by Platform), 2020-2031 ........................... 117 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 10.1Overview ......................................................................................................... 117 10.2Next-Generation Sequencing ........................................................................ 119 10.3PCR ................................................................................................................. 121 10.4Others ............................................................................................................. 123 11.Global NIPT Market (by Application), 2020-2031 ....................... 126 11.1Overview ......................................................................................................... 126 11.2Trisomy Detection ......................................................................................... 128 11.3Microdeletion Detection ................................................................................ 130 11.4Sex Chromosome Aneuploidy Detection ..................................................... 132 11.5Others ............................................................................................................. 134 6 All rights reserved at BIS Research Inc.

  7. 12.Global NIPT Market (by End User), 2020-2031 .......................... 136 12.1Overview ......................................................................................................... 136 12.2Hospital .......................................................................................................... 138 12.3Clinics ............................................................................................................. 139 12.4Diagnostic Labs ............................................................................................. 141 12.5Others ............................................................................................................. 142 13.Global NIPT Market (by Region), 2020-2031 ............................. 144 13.1Overview ......................................................................................................... 144 13.2North America ................................................................................................ 148 13.2.1Overview .................................................................................................... 148 13.2.1.1 By Value and Volume ....................................................................................... 148 13.2.1.2 By Value and Volume (by Country) ................................................................... 150 13.2.1.3 Pricing Analysis by Leading NIPT Test ............................................................. 151 13.2.2U.S. ............................................................................................................. 152 13.2.2.1 By Value............................................................................................................ 152 13.2.2.2 By Volume ......................................................................................................... 153 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 13.2.2.3 Organizations Offering NIPT Test ..................................................................... 154 13.2.2.4 Market Share Analysis ...................................................................................... 155 13.2.2.5 Pricing Analysis by Leading NIPT Test ............................................................. 156 13.2.3Canada ....................................................................................................... 157 13.2.3.1 By Value............................................................................................................ 157 13.2.3.2 By Volume ......................................................................................................... 157 13.2.3.3 Organizations Offering NIPT Test ..................................................................... 158 13.2.3.4 Market Share Analysis ...................................................................................... 159 13.2.3.5 Pricing Analysis by Leading NIPT Test ............................................................. 160 13.3Europe ............................................................................................................ 162 13.3.1Overview .................................................................................................... 162 13.3.1.1 By Value and Volume ....................................................................................... 162 7 All rights reserved at BIS Research Inc.

  8. 13.3.1.2 By Value and Volume (by Country) ................................................................... 164 13.3.1.3 Pricing Analysis by Leading NIPT Test ............................................................. 166 13.3.2Germany ..................................................................................................... 167 13.3.2.1 By Value............................................................................................................ 167 13.3.2.2 By Volume ......................................................................................................... 168 13.3.2.3 Organizations Offering NIPT Test ..................................................................... 169 13.3.2.4 Market Share Analysis ...................................................................................... 170 13.3.3France ......................................................................................................... 171 13.3.3.1 By Value............................................................................................................ 171 13.3.3.2 By Volume ......................................................................................................... 171 13.3.3.3 Organizations Offering NIPT Test ..................................................................... 172 13.3.3.4 Market Share Analysis ...................................................................................... 173 13.3.4Italy ............................................................................................................. 174 13.3.4.1 By Value............................................................................................................ 174 13.3.4.2 By Volume ......................................................................................................... 175 13.3.4.3 Organizations Offering NIPT Test ..................................................................... 175 13.3.4.4 Market Share Analysis ...................................................................................... 177 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 13.3.5U.K. ............................................................................................................. 177 13.3.5.1 By Value............................................................................................................ 177 13.3.5.2 By Volume ......................................................................................................... 178 13.3.5.3 Organizations Offering NIPT Test ..................................................................... 179 13.3.5.4 Market Share Analysis ...................................................................................... 181 13.3.6Spain ........................................................................................................... 182 13.3.6.1 By Value............................................................................................................ 182 13.3.6.2 By Volume ......................................................................................................... 183 13.3.6.3 Organizations Offering NIPT Test ..................................................................... 183 13.3.6.4 Market Share Analysis ...................................................................................... 184 13.3.7Russia ......................................................................................................... 185 13.3.7.1 By Value............................................................................................................ 185 8 All rights reserved at BIS Research Inc.

  9. 13.3.7.2 By Volume ......................................................................................................... 186 13.3.7.3 Organizations Offering NIPT Test ..................................................................... 187 13.3.7.4 Market Share Analysis ...................................................................................... 187 13.3.8Poland ........................................................................................................ 188 13.3.8.1 By Value............................................................................................................ 188 13.3.8.2 By Volume ......................................................................................................... 189 13.3.8.3 Organizations Offering NIPT Test ..................................................................... 190 13.3.8.4 Market Share Analysis ...................................................................................... 191 13.3.9Netherlands ................................................................................................ 192 13.3.9.1 By Value............................................................................................................ 192 13.3.9.2 By Volume ......................................................................................................... 192 13.3.9.3 Organizations Offering NIPT Test ..................................................................... 193 13.3.9.4 Market Share Analysis ...................................................................................... 194 13.3.10 Belgium ................................................................................................ 194 13.3.10.1 By Value .......................................................................................................... 194 13.3.10.2 By Volume ....................................................................................................... 195 13.3.10.3 Organizations Offering NIPT Test .................................................................... 195 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 13.3.10.4 Market Share Analysis ..................................................................................... 196 13.3.11 Switzerland .......................................................................................... 197 13.3.11.1 By Value .......................................................................................................... 197 13.3.11.2 By Volume ....................................................................................................... 198 13.3.11.3 Organizations Offering NIPT Test .................................................................... 198 13.3.11.4 Market Share Analysis ..................................................................................... 199 13.3.12 Denmark ............................................................................................... 200 13.3.12.1 By Value .......................................................................................................... 200 13.3.12.2 By Volume ....................................................................................................... 200 13.3.12.3 Organizations Offering NIPT Test .................................................................... 201 13.3.12.4 Market Share Analysis ..................................................................................... 202 13.3.13 Sweden ................................................................................................ 203 9 All rights reserved at BIS Research Inc.

  10. 13.3.13.1 By Value .......................................................................................................... 203 13.3.13.2 By Volume ....................................................................................................... 203 13.3.13.3 Organizations Offering NIPT Test .................................................................... 204 13.3.13.4 Market Share Analysis ..................................................................................... 205 13.3.14 Rest-of-Europe .................................................................................... 205 13.3.14.1 By Value .......................................................................................................... 205 13.3.14.2 By Volume ....................................................................................................... 206 13.4Asia-Pacific .................................................................................................... 207 13.4.1Overview .................................................................................................... 207 13.4.1China .......................................................................................................... 211 13.4.1.1 By Value............................................................................................................ 211 13.4.1.2 By Volume ......................................................................................................... 212 13.4.2Japan .......................................................................................................... 213 13.4.2.1 By Value............................................................................................................ 213 13.4.2.2 By Volume ......................................................................................................... 214 13.4.3India ............................................................................................................ 215 13.4.3.1 By Value............................................................................................................ 215 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 13.4.3.2 By Volume ......................................................................................................... 216 13.4.4Australia ..................................................................................................... 217 13.4.4.1 By Value............................................................................................................ 217 13.4.4.2 By Volume ......................................................................................................... 218 13.4.5South Korea ............................................................................................... 219 13.4.5.1 By Value............................................................................................................ 219 13.4.5.2 By Volume ......................................................................................................... 219 13.4.6Hong Kong ................................................................................................. 220 13.4.6.1 By Value............................................................................................................ 220 13.4.6.2 By Volume ......................................................................................................... 221 13.4.7Malaysia ..................................................................................................... 221 13.4.7.1 By Value............................................................................................................ 221 10 All rights reserved at BIS Research Inc.

  11. 13.4.7.2 By Volume ......................................................................................................... 222 13.4.8Indonesia .................................................................................................... 222 13.4.8.1 By Value............................................................................................................ 222 13.4.8.2 By volume ......................................................................................................... 223 13.4.9Vietnam ...................................................................................................... 223 13.4.9.1 By Value............................................................................................................ 223 13.4.9.2 By Volume ......................................................................................................... 224 13.4.10 Thailand ............................................................................................... 224 13.4.10.1 By Value .......................................................................................................... 224 13.4.10.2 By Volume ....................................................................................................... 225 13.4.11 Philippines ........................................................................................... 225 13.4.11.1 By Value .......................................................................................................... 225 13.4.11.2 By Volume ....................................................................................................... 226 13.4.12 Rest-of-APAC ...................................................................................... 226 13.4.12.1 By Value .......................................................................................................... 226 13.4.12.2 By Volume ....................................................................................................... 227 13.5Latin America ................................................................................................. 228 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 13.5.1By Value ..................................................................................................... 228 13.5.2By Volume .................................................................................................. 229 13.6Rest-of-the-World .......................................................................................... 230 13.6.1By Value ..................................................................................................... 230 13.6.2By Volume .................................................................................................. 231 14.Company Profiles ..................................................................... 232 14.1Overview ......................................................................................................... 232 14.2Agilent Technologies, Inc. ............................................................................ 233 14.2.1Company Overview ................................................................................... 233 14.2.2Role of Agilent Technologies, Inc. in the Global NIPT Market ............... 233 14.2.3Financials ................................................................................................... 234 14.2.4Key Insights About Financial Health of the Company ........................... 236 11 All rights reserved at BIS Research Inc.

  12. 14.2.5SWOT Analysis .......................................................................................... 237 14.3F. Hoffmann-La Roche Ltd ............................................................................ 238 14.3.1Company Overview ................................................................................... 238 14.3.2Role of F. Hoffmann-La Roche Ltd in the Global NIPT Market .............. 238 14.3.3Financials ................................................................................................... 240 14.3.4Key Insights About Financial Health of the Company ........................... 241 14.3.5SWOT Analysis .......................................................................................... 242 14.4PerkinElmer, Inc. ............................................................................................ 243 14.4.1Company Overview ................................................................................... 243 14.4.2Role of PerkinElmer, Inc. in the Global NIPT Market .............................. 243 14.4.3Financials ................................................................................................... 245 14.4.4Key Insights About Financial Health of the Company ........................... 246 14.4.5SWOT Analysis .......................................................................................... 247 14.5Quest Diagnostics Incorporated .................................................................. 248 14.5.1Company Overview ................................................................................... 248 14.5.2Role of Quest Diagnostics Incorporated in the Global NIPT Market ..... 248 14.5.3Financials ................................................................................................... 249 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 14.5.4SWOT Analysis .......................................................................................... 251 14.6Illumina, Inc. ................................................................................................... 252 14.6.1Company Overview ................................................................................... 252 14.6.2Role of Illumina, Inc. in the Global NIPT Market ..................................... 252 14.6.3Financials ................................................................................................... 254 14.6.4Key Insights About Financial Health of the Company ........................... 256 14.6.5SWOT Analysis .......................................................................................... 257 14.7Myriad Genetics, Inc. ..................................................................................... 258 14.7.1Company Overview ................................................................................... 258 14.7.2Role of Myriad Genetics, Inc. in the NIPT Market ................................... 258 14.7.3Financials ................................................................................................... 260 14.7.4Key Insights About Financial Health of the Company ........................... 261 12 All rights reserved at BIS Research Inc.

  13. 14.7.5SWOT Analysis .......................................................................................... 262 14.8BGI .................................................................................................................. 263 14.8.1Company Overview ................................................................................... 263 14.8.2Role of BGI in the NIPT Market ................................................................. 263 14.8.3SWOT Analysis .......................................................................................... 265 14.9CENTOGENE N.V. .......................................................................................... 266 14.9.1Company Overview ................................................................................... 266 14.9.2Role of CENTOGENE N.V. in the NIPT Market ........................................ 266 14.9.3Financials ................................................................................................... 267 14.9.4Key Insights About Financial Health of the Company ........................... 269 14.9.5SWOT Analysis .......................................................................................... 270 14.10Laboratory Corporation of America Holdings ............................................. 271 14.10.1 Company Overview ............................................................................. 271 14.10.2 Role of Laboratory Corporation of America Holdings in the NIPT Market ................................................................................................ 271 14.10.3 Financials ............................................................................................ 273 14.10.4 SWOT Analysis .................................................................................... 275 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 14.11MedGenome Inc. ............................................................................................ 276 14.11.1 Company Overview ............................................................................. 276 14.11.2 Role of MedGenome Inc. in the Global NIPT Market ........................ 276 14.11.3 SWOT Analysis .................................................................................... 278 14.12Annoroad Gene Technology ......................................................................... 279 14.12.1 Company Overview ............................................................................. 279 14.12.2 Role of Annoroad Gene Technology in the NIPT Market ................. 279 14.12.3 SWOT Analysis .................................................................................... 281 14.13Natera, Inc. ..................................................................................................... 282 14.13.1 Company Overview ............................................................................. 282 14.13.2 Role of Natera, Inc. in the Global NIPT Market ................................. 282 14.13.3 Financials ............................................................................................ 284 13 All rights reserved at BIS Research Inc.

  14. 14.13.4 Key Insights About Financial Health of the Company ..................... 285 14.13.5 SWOT Analysis .................................................................................... 286 14.14Yourgene Health PLC .................................................................................... 287 14.14.1 Company Overview ............................................................................. 287 14.14.2 Role of Yourgene Health PLC in the NIPT Market ............................ 287 14.14.3 Financials ............................................................................................ 289 14.14.4 SWOT Analysis .................................................................................... 290 14.15Next Biosciences ........................................................................................... 291 14.15.1 Company Overview ............................................................................. 291 14.15.2 Role of Next Biosciences in the NIPT Market ................................... 291 14.15.3 SWOT Analysis .................................................................................... 293 14.16Eurofins Scientific ......................................................................................... 294 14.16.1 Company Overview ............................................................................. 294 14.16.2 Role of Eurofins Scientific in the NIPT Market ................................. 294 14.16.3 Financials ............................................................................................ 296 14.16.4 SWOT Analysis .................................................................................... 297 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 14 All rights reserved at BIS Research Inc.

  15. List of Figures Figure 1:Global NIPT Market (by Region), by Revenue, $Million, 2020-2031 Figure 2:Global NIPT Market (by Region), by Volume, Thousand Units, 2020 and 2031 Figure 3:Impact of Market Drivers and Market Restraints Figure 4:Share of Key Developments and Strategies, January 2017-October 2021 Figure 5:Market Statistics Figure 6:Global NIPT Market Share (by Test), 2020-2031 Figure 7:Global NIPT Market Share (by Method), 2020-2031 Figure 8:Global NIPT Market Share (by Platform), 2020-2031 Figure 9:Global NIPT Market Share (by Application), 2020-2031 Figure 10:Global NIPT Market Share (by End User), 2020-2031 Figure 11:Global NIPT Market Segmentation Figure 12:Global NIPT Market Methodology Figure 13:Primary Research Methodology Figure 14:Bottom-Up Approach (Segment-Wise Analysis) Figure 15:Top-Down Approach (Segment-Wise Analysis) Figure 16:Prenatal Testing Timeline During Pregnancy Figure 17:Different Indications for NIPT Figure 18:NIPT Approach GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Figure 19:Benefits and Risks of NIPT Figure 20:Features of the Major Chromosome Aneuploidies Figure 21:Incidence Rate of Major Chromosome Aneuploidies Figure 22:Ecosystem Players of Global Non-Invasive Prenatal Testing Market Figure 23:Global NIPT Market, by Revenue, $Million, 2020-2031 Figure 24:Global NIPT Market, by Volume, Thousand Units, 2020-2031 Figure 25:Number of Tests Processed by Natera, Inc., 2018-2020 Figure 26:NGS-Based Screening Technologies by Major Companies Figure 27:Reimbursement Policies Covering Prenatal Testing in the Europe Market Figure 28:Births with Down’s Syndrome per 100,000 Live Births in Europe Region (2011-2018) Figure 29:Examples of Investment and Funding by Key Companies Figure 30:Classification of Tests in CLIA Program Figure 31:Cost Range of NIPT in Major Countries Figure 32:Reimbursement Scenario in Major Countries of the Global NIPT Market 15 All rights reserved at BIS Research Inc.

  16. Figure 33:Supply Chain of Global NIPT Market Figure 34:Pre-COVID and Post-COVID Growth Trend of the Global NIPT Market, 2020-2025 Figure 35:Competitive Landscape (January 2017-October 2021) Figure 36:Share of Key Developments and Strategies, January 2017-October 2021 Figure 37:New Offerings (by Company), January 2017-October 2021 Figure 38:Partnerships and Alliances (by Company), January 2017-October 2021 Figure 39:Product Approvals (by Company), January 2017-October 2021 Figure 40:Business Expansions (by Company), January 2017-October 2021 Figure 41:Merger and Acquisition Activities (by Company), January 2017-October 2021 Figure 42:Market Share Analysis of Global NIPT Market, 2020 Figure 43:Growth Share Matrix for NIPT Market (by Platform), 2019-2020 Figure 44:Global NIPT Segmentation (by Test) Figure 45:Global NIPT Market (by Test), by Revenue, $Million, 2020-2031 Figure 46:Global NIPT Market for Panorama and Vistara (by Revenue), $Million, 2020-2031 Figure 47:Global NIPT Market for MaterniT GENOME, MaterniT 21 PLUS, and informaSeq, (by Revenue), $Million, 2020-2031 Figure 48:Global NIPT Market for Verifi and Verifi Plus Prenatal Tests (by Revenue), $Million, 2020- 2031 Figure 49:Global NIPT Market for Harmony Test (by Revenue), $Million, 2020-2031 Figure 50:Global NIPT Market for NIFTY Test and NIFTY Test Pro (by Revenue), $Million, 2020-2031 Figure 51:Global NIPT Market for QNatal Advanced (by Revenue), $Million, 2020-2031 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Figure 52:Global NIPT Market for PrenaTest, GeneSafe, and PrenatalSAFE (by Revenue), $Million, 2020-2031 Figure 53:Global NIPT Market for Bambni Test (by Revenue), $Million, 2020-2031 Figure 54:Global NIPT Market for IONA and Sage (by Revenue), $Million, 2020-2031 Figure 55:Global NIPT Market for Other Tests (by Revenue), $Million, 2020-2031 Figure 56:Global NIPT Segmentation (by Method) Figure 57:Global NIPT Market (by Method), by Revenue, $Million, 2020-2031 Figure 58:Global NIPT Market (by Method), by Volume, Thousand Units, 2020-2031 Figure 59:Global NIPT Market for cfDNA (by Revenue), $Million, 2020-2031 Figure 60:Global NIPT Market for cfDNA (by Volume), Thousand Units, 2020-2031 Figure 61:Global NIPT Market for FCMB (by Revenue), $Million, 2020-2031 Figure 62:Global NIPT Market for FCMB (by Volume), Thousand Units, 2020-2031 Figure 63:Global NIPT Segmentation (by Platform) Figure 64:Global NIPT Market (by Platform), by Revenue, $Million, 2020-2031 16 All rights reserved at BIS Research Inc.

  17. Figure 65:Global NIPT Market (by Platform), by Volume, Thousand Units, 2020-2031 Figure 66:Global NIPT Market for NGS (by Revenue), $Million, 2020-2031 Figure 67:Global NIPT Market for NGS (by Volume), Thousand Units, 2020-2031 Figure 68:Global NIPT Market for PCR (by Revenue), $Million, 2020-2031 Figure 69:Global NIPT Market for PCR (by Volume), Thousand Units, 2020-2031 Figure 70:Global NIPT Market for Other Platforms (by Revenue), $Million, 2020-2031 Figure 71:Global NIPT Market for Other Platforms (by Volume), Thousand Units, 2020-2031 Figure 72:Global NIPT Segmentation (by Application) Figure 73:Global NIPT Market (by Application), by Revenue, $Million, 2020-2031 Figure 74:Global NIPT Market (by Application), by Volume, Thousand Units, 2020-2031 Figure 75:Global NIPT Market for Trisomy Detection (by Revenue), $Million, 2020-2031 Figure 76:Global NIPT Market for Trisomy Detection (by Volume), Thousand Units, 2020-2031 Figure 77:Global NIPT Market for Microdeletion Detection (by Revenue), $Million, 2020-2031 Figure 78:Global NIPT Market for Microdeletion Detection (by Volume), Thousand Units, 2020-2031 Figure 79:Global NIPT Market for Sex Chromosome Aneuploidy Detection (by Revenue), $Million, 2020-2031 Figure 80:Global NIPT Market for Sex Chromosome Aneuploidy Detection (by Volume), Thousand Units, 2020-2031 Figure 81:Global NIPT Market for Others (by Revenue), $Million, 2020-2031 Figure 82:Global NIPT Market for Others (by Volume), Thousand Units, 2020-2031 Figure 83:Global NIPT Segmentation (by End User) GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Figure 84:Global NIPT Market (by End User), by Revenue, $Million, 2020 and 2031 Figure 85:Global NIPT Market (by End User), by Volume, Thousand Units, 2020 and 2031 Figure 86:Global NIPT Market for Hospital (by Revenue), $Million, 2020 and 2031 Figure 87:Global NIPT Market for Hospital (by Volume), Thousand Units, 2020 and 2031 Figure 88:Global NIPT Market for Clinics (by Revenue), $Million, 2020 and 2031 Figure 89:Global NIPT Market for Clinics (by Volume), Thousand Units, 2020 and 2031 Figure 90:Global NIPT Market for Diagnostic Labs (by Revenue), $Million, 2020 and 2031 Figure 91:Global NIPT Market for Diagnostic Labs (by Volume), Thousand Units, 2020 and 2031 Figure 92:Global NIPT Market for Others (by Revenue), $Million, 2020 and 2031 Figure 93:Global NIPT Market for Others (by Volume), Thousand Units, 2020 and 2031 Figure 94:Global NIPT Market (by Region) Figure 95:Global NIPT Market (by Region), by Revenue, $Million, 2020-2031 Figure 96:Global NIPT Market (by Region), $Million, 2020-2031 Figure 97:Global NIPT Market (by Region), by Volume, Thousand Units, 2020 and 2031 17 All rights reserved at BIS Research Inc.

  18. Figure 98:Global NIPT Market (by Region), Thousand Units, 2020-2031 Figure 99:North America: NIPT Market (by Revenue), $Million, 2020-2031 Figure 100:North America: NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 101:North America: Market Dynamics Figure 102:North America: NIPT Market Share (by Country), by Revenue, $Million, 2020 and 2031 Figure 103:North America: NIPT Market Share (by Country), by Volume, Thousand Units, 2020 and 2031 Figure 104:Pricing Analysis by Leading NIPT Test, 2020 Figure 105:U.S. NIPT Market (by Revenue), $Million, 2020-2031 Figure 106:U.S. NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 107:Organizations Offering NIPT Test in United States Figure 108:Market Share Analysis of U.S. NIPT Market, $Million, 2020 Figure 109:Pricing Analysis by Leading NIPT Test in U.S., 2020 Figure 110:Canada NIPT Market (by Revenue), $Million, 2020-2031 Figure 111:Canada NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 112:Organizations Offering NIPT Test in Canada Figure 113:Market Share Analysis of Canada NIPT Market, $Million, 2020 Figure 114:Pricing Analysis by Leading NIPT Test in Canada, 2020 Figure 115:Europe: NIPT Market (by Revenue), $Million, 2020-2031 Figure 116:Europe NIPT Market (by Volume), Thousand Units, 2020-2031 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Figure 117:Europe Market Dynamics Figure 118:Europe: NIPT Market Share (by Country), by Revenue, $Million 2020 and 2031 Figure 119:Europe: NIPT Market Share (by Country), by Volume, Thousand Units 2020 and 2031 Figure 120:Pricing Analysis by Leading NIPT Test in EU-5, 2020 Figure 121:Germany NIPT Market (by Revenue), $Million, 2020-2031 Figure 122:Germany NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 123:Organizations Offering NIPT Test in Germany Figure 124:Market Share Analysis of Germany NIPT Market, $Million, 2019-2020 Figure 125:France NIPT Market (by Revenue), $Million, 2020-2031 Figure 126:France NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 127:Organizations Offering NIPT Test in France Figure 128:Market Share Analysis of France NIPT Market, $Million, 2019-2020 Figure 129:Italy NIPT Market (by Revenue), $Million, 2020-2031 Figure 130:Italy NIPT Market (by Volume), Thousand Units, 2020-2031 18 All rights reserved at BIS Research Inc.

  19. Figure 131:Organizations Offering NIPT Test in Italy Figure 132:Market Share Analysis of Italy NIPT Market, $Million, 2019-2020 Figure 133:U.K. NIPT Market (by Revenue), $Million, 2020-2031 Figure 134:U.K. NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 135:Organizations Offering NIPT Test in the U.K. Figure 136:Market Share Analysis of U.K. NIPT Market, $Million, 2019-2020 Figure 137:Spain NIPT Market (by Revenue), $Million, 2020-2031 Figure 138:Spain NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 139:Organizations Offering NIPT Test in the Spain Figure 140:Market Share Analysis of Spain NIPT Market, $Million, 2019-2020 Figure 141:Russia NIPT Market (by Revenue), $Million, 2020-2031 Figure 142:Russia NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 143:Organizations Offering NIPT Test in the Russia Figure 144:Market Share Analysis of Russia NIPT Market, $Million, 2019-2020 Figure 145:Poland NIPT Market (by Revenue), $Million, 2020-2031 Figure 146:Poland NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 147:Organizations Offering NIPT Test in Poland Figure 148:Market Share Analysis of Poland NIPT Market, $Million, 2019-2020 Figure 149:Netherlands NIPT Market (by Revenue), $Million, 2020-2031 Figure 150:Netherlands NIPT Market (by Volume), Thousand Units, 2020-2031 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Figure 151:Organizations Offering NIPT Test in Netherlands Figure 152:Market Share Analysis of Netherlands NIPT Market, $Million, 2019-2020 Figure 153:Belgium NIPT Market (by Revenue), $Million, 2020-2031 Figure 154:Belgium NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 155:Organizations Offering NIPT Test in Belgium Figure 156:Market Share Analysis of Belgium NIPT Market, $Million, 2019-2020 Figure 157:Switzerland NIPT Market (by Revenue), $Million, 2020-2031 Figure 158:Switzerland NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 159:Organizations Offering NIPT Test in Switzerland Figure 160:Market Share Analysis of Switzerland NIPT Market, $Million, 2019-2020 Figure 161:Denmark NIPT Market (by Revenue), $Million, 2020-2031 Figure 162:Denmark NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 163:Organizations Offering NIPT Test in Denmark Figure 164:Market Share Analysis of Denmark NIPT Market, $Million, 2019-2020 19 All rights reserved at BIS Research Inc.

  20. Figure 165:Sweden NIPT Market (by Revenue), $Million, 2020-2031 Figure 166:Sweden NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 167:Organizations Offering NIPT Test in Sweden Figure 168:Market Share Analysis of Sweden NIPT Market, $Million, 2019-2020 Figure 169:Rest-of-Europe NIPT Market (by Revenue), $Million, 2020-2031 Figure 170:Rest-of-Europe NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 171:APAC NIPT Market (by Revenue), $Million, 2020-2031 Figure 172:APAC: NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 173:APAC Market Dynamics Figure 174:APAC NIPT Market Share (by Country), by Revenue, 2020 and 2031 Figure 175:APAC NIPT Market Share (by Country), by Volume, 2020 and 2031 Figure 176:China NIPT Market (by Revenue), $Million, 2020-2031 Figure 177:China NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 178:Japan NIPT Market (by Revenue), $Million, 2020-2031 Figure 179:Japan NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 180:India NIPT Market (by Revenue), $Million, 2020-2031 Figure 181:India NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 182:Australia NIPT Market (by Revenue), $Million, 2020-2031 Figure 183:Australia NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 184:South Korea NIPT Market (by Revenue), $Million, 2020-2031 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Figure 185:South Korea NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 186:Hong Kong NIPT Market (by Revenue), $Million, 2020-2031 Figure 187:Hong Kong NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 188:Malaysia NIPT Market (by Revenue), $Million, 2020-2031 Figure 189:Malaysia NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 190:Indonesia NIPT Market (by Revenue), $Million, 2020-2031 Figure 191:Indonesia NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 192:Vietnam NIPT Market (by Revenue), $Million, 2020-2031 Figure 193:Vietnam NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 194:Thailand NIPT Market (by Revenue), $Million, 2020-2031 Figure 195:Thailand NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 196:Philippines NIPT Market (by Revenue), $Million, 2020-2031 Figure 197:Philippines NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 198:Rest-of-APAC NIPT Market (by Revenue), $Million, 2020-2031 20 All rights reserved at BIS Research Inc.

  21. Figure 199:Rest-of-APAC NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 200:LATAM NIPT Market (by Revenue), $Million, 2020-2031 Figure 201:LATAM NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 202:RoW NIPT Market (by Revenue), $Million, 2020-2031 Figure 203:RoW NIPT Market (by Volume), Thousand Units, 2020-2031 Figure 204:Shares of Key Company Profiles Figure 205:Agilent Technologies, Inc.: Product Portfolio for Global NIPT Market Figure 206:Agilent Technologies, Inc.: Overall Financials/Revenue, $Million, 2018-2020 Figure 207:Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2018-2020 Figure 208:Agilent Technologies, Inc.: Revenue (By Region), $Millions, 2018-2020 Figure 209:Agilent Technologies, Inc.: R&D Expenditure, $Millions, 2018-2019 Figure 210:Agilent Technologies, Inc.: SWOT Analysis Figure 211:Hoffmann-La Roche Ltd: Product Portfolio for Global NIPT Market Figure 212:F. Hoffmann-La Roche Ltd: Overall Financials/Revenue, $Billion, 2018-2020 Figure 213:F. Hoffmann-La Roche Ltd: Revenue (by Segment), Billions, 2018-2020 Figure 214:F. Hoffmann-La Roche Ltd: Revenue (by Region), Billions, 2018-2020 Figure 215:F. Hoffmann-La Roche Ltd: R&D Expenditure, Billions, 2018-2020 Figure 216:F. Hoffmann-La Roche Ltd: SWOT Analysis Figure 217:PerkinElmer, Inc.: Product Portfolio for Global NIPT Market Figure 218:PerkinElmer, Inc.: Overall Financials/Revenue, $Million, 2018-2020 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Figure 219:PerkinElmer, Inc.: Revenue (by Segment), Millions, 2018-2020 Figure 220:PerkinElmer, Inc.: Revenue (by Region), Millions, 2018-2020 Figure 221:PerkinElmer, Inc.: R&D Expenditure, Millions, 2018-2020 Figure 222:PerkinElmer, Inc.: SWOT Analysis Figure 223:Quest Diagnostics Incorporated’s Product Portfolio for Global NIPT Market Figure 224:Quest Diagnostics Incorporated.: Overall Financials/Revenue, $Million, 2018-2020 Figure 225:Quest Diagnostics Incorporated, Revenue (by Segment), Millions, 2018-2020 Figure 226:Quest Diagnostics Incorporated, SWOT Analysis Figure 227:Illumina, Inc.: Product Portfolio for Global NIPT Market Figure 228:Illumina, Inc.: Overall Financials/Revenue, $Million, 2018-2020 Figure 229:Illumina, Inc.: Revenue (by Segment), Millions, 2018-2020 Figure 230:Illumina, Inc.: Revenue (by Region), Millions, 2018-2020 Figure 231:Illumina, Inc.: R&D Expenditure, Millions, 2018-2020 Figure 232:Illumina, Inc.: SWOT Analysis 21 All rights reserved at BIS Research Inc.

  22. Figure 233:Myriad Genetics, Inc.: Product Portfolio for Global NIPT Market Figure 234:Myriad Genetics, Inc.: Overall Financials/Revenue, $Million, 2018-2020 Figure 235:Myriad Genetics, Inc.: Revenue (by Product/Service), Millions, 2018-2020 Figure 236:Myriad Genetics, Inc.: R&D Expenditure, Millions, 2018-2020 Figure 237:Myriad Genetics, Inc.: SWOT Analysis Figure 238:BGI: Product Portfolio for Global NIPT Market Figure 239:BGI: SWOT Analysis Figure 240:CENTOGENE N.V.: Product Portfolio for Global NIPT Market Figure 241:CENTOGENE N.V.: Overall Financials/Revenue, $Million, 2018-2020 Figure 242:CENTOGENE N.V.: Revenue (by Segment), Millions, 2018-2020 Figure 243:CENTOGENE N.V.: Revenue (by Region), Millions, 2018-2020 Figure 244:CENTOGENE N.V.: R&D Expenditure, Millions, 2018-2020 Figure 245:CENTOGENE N.V.: SWOT Analysis Figure 246:Laboratory Corporation of America Holdings: Product Portfolio for Global NIPT Market Figure 247:Laboratory Corporation of America Holdings: Overall Financials/Revenue, $Million, 2018- 2020 Figure 248:Laboratory Corporation of America Holdings: Revenue (by Segment), Millions, 2018-2020 Figure 249:Laboratory Corporation of America Holdings: Revenue (By Region), Millions, 2018-2020 Figure 250:Laboratory Corporation of America Holdings: SWOT Analysis Figure 251:MedGenome Inc.: Product Portfolio for Global NIPT Market GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Figure 252:MedGenome Inc.: SWOT Analysis Figure 253:Annoroad Gene Technology: Product Portfolio for Global NIPT Market Figure 254:Annoroad Gene Technology: SWOT Analysis Figure 255:Natera, Inc.: Product Portfolio for Global NIPT Market Figure 256:Natera, Inc.: Overall Financials/Revenue, $Million, 2018-2020 Figure 257:Natera, Inc.: Revenue (by Region), Millions, 2018-2020 Figure 258:Natera, Inc.: R&D Expenditure, Millions, 2018-2020 Figure 259:Natera, Inc.: SWOT Analysis Figure 260:Yourgene Health PLC: Product Portfolio for Global NIPT Market Figure 261:Yourgene Health PLC: Overall Financials/Revenue, $Million, 2018-2020 Figure 262:Yourgene Health PLC: Revenue (by Region), Millions, 2018-2020 Figure 263:Yourgene Health PLC: SWOT Analysis Figure 264:Next Biosciences: Product Portfolio for Global NIPT Market Figure 265:Next Biosciences SWOT Analysis 22 All rights reserved at BIS Research Inc.

  23. Figure 266:Eurofins Scientific: Product Portfolio for Global NIPT Market Figure 267:Eurofins Scientific Overall Financials/Revenue, $Million, 2018-2020 Figure 268:Eurofins Scientific Revenue (by Region), Millions, 2018-2020 Figure 269:Eurofins Scientific: SWOT Analysis GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 23 All rights reserved at BIS Research Inc.

  24. List of Tables Table 1: Major Chromosomal Aneuploidies Table 2: Technological Approach for NIPT Table 3: Impact Analysis of Market Drivers Table 4: Impact Analysis of Market Restraints Table 5: Risk of Chromosomal Abnormality w.r.t Maternal Age Table 6: Chromosome (Gene) Defects Prevalence Per Year in the U.S. Table 7: List of Regulatory Authorities Involved in CLIA Program Table 8: Major Funding Activities (January 2017-June 2020) Table 9: Key Companies Offering cfDNA-Based NIPT Solution Table 10:Key Companies Offering FCMB-Based NIPT Solution Table 11:Key Companies Offering NGS-Based NIPT Solution Table 12:Key Companies Offering PCR-Based NIPT Solution Table 13:Key Companies Offering Other Platform-Based NIPT Solution Table 14:Key Companies Offering NIPT Solution for Trisomy Detection Table 15:Key Companies Offering NIPT Solution for Microdeletion Detection Table 16:Key Companies Offering NIPT Solution for SCA Detection GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 24 All rights reserved at BIS Research Inc.

  25. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have a vision to be a leading and preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET Know More Know More Know More Know More 25 All rights reserved at BIS Research Inc.

  26. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties, and contingencies. For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET 26 All rights reserved at BIS Research Inc.

  27. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540/4261544 27 www.bisresearch.com All rights reserved at BIS Research Inc.

More Related